Hemato-Oncology Testing Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Hemato-Oncology Testing Market By Product & Service (Services and Assay kit), By Cancer Type (Leukemia, Acute myeloid leukemia, Acute lymphocytic leukemia, Lymphoma, Non-Hodgkin lymphoma, Hodgkin lymphoma, and others), By Technology (PCR, IHC, NGS, Cytogenetics, and others), By End User (Clinical laboratories, Hospitals, Academic & Research institute, and others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Hemato-Oncology Testing Market size was valued at 2.5 billion in 2021 and is expected to reach 5.8 billion by 2028, at a CAGR of 14.8% during the forecast period 2022 to 2028. There is a high rise in the number of patients suffering from blood and tumor diseases, which has been the key reason for substantial growth in the hemato-oncology market. Growing hematological cancer prevalence, developing partnerships to create new assays, and growing knowledge of customized medicines. In addition, the recent increase in the geriatric population is another integral factor driving the global demand for hemato-oncology. However, it is expected that unclear reimbursements in various regions will hinder market development. The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.

Hemato-Oncology Testing Market

MARKET SUMMARY
-
14.8%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 14.8%
  • Largest Market– Europe
  • Fastest Growing Market– North-America

Hemato-Oncology Testing Market

  • The global hemato-oncology testing market report gives comprehensive outlook on hemato-oncology testing across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global market gives historical, current, and future market sizes (US$ Mn) on the basis of product & service, cancer type, technology, end user, and region.
  • Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions and market unmet needs.
Key Players
  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
Hemato-Oncology Testing Market

DRIVERS AND RESTRAINTS

The key trend is the discovery and development of new tests and therapies, with companies operating in the global market for hemato oncology testing continuing to compete. Their growing engagement in partnerships and alliances is proving to be very advantageous for the growth of the business. Nonetheless, the high demand for PCR and NGS technologies for testing and diagnosis of hemato oncology would in the long run normalize the effect of these restricting factors.


North-America Got Significant Share

Hemato-Oncology Testing Market

For the past few years, North America has been leading the global economy. This regional market has been assisted by the availability of advanced medical and healthcare facilities and the early adoption of advanced technologies. In the years to come, the involvement of key players and continuous study in the field of oncology will continue to drive the demand for North American hemato oncology testing.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Developments

  • In May 2019, Adaptive Biotechnologies collaborated with Sanofi, SA. to utilize Adaptive’s clonoSEQ Assay to measure MRD status in response to isatuximab.
  • In July 2019, Abbott Laboratories received FDA approval for its Abbott RealTime IDH1 kit.
  • In May 2019, Invivoscribe, Inc. partnered with the American University of Beirut Medical Center (AUBMC) to create a new center of excellence facility in the Middle East.

Key

Findings of the Report


Key

Features of the Report

Hemato-Oncology Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global Hemato-Oncology Testing Market Introduction
    • Global Hemato-Oncology Testing Market – Taxonomy
    • Global Hemato-Oncology Testing Market –Definitions
      • By Product & Service
      • By Cancer Type
      • By Technology
      • By End User
      • By Region
  1. Global Hemato-Oncology Testing Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Hemato-Oncology Testing Market Dynamic Factors – Impact Analysis
    • Global Hemato-Oncology Testing Market – Competition Landscape
  2. Global Hemato-Oncology Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Hemato-Oncology Testing Market, By Product & Service, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Services
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Assay kits
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemato-Oncology Testing Market Forecast, By Cancer Type, 2015 – 2019 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Leukemia
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Acute myeloid leukemia
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Acute lymphocytic leukemia
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Lymphoma
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Non-Hodgkin lymphoma
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hodgkin lymphoma
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemato-Oncology Testing Market Forecast, By Technology, 2015 – 2019 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • PCR
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • IHC
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • NGS
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cytogenetics
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemato-Oncology Testing Market, By End User, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Clinical laboratories
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hospitals
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Academic & Research Institutes
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Other end user
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemato-Oncology Testing Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Hemato-Oncology Testing Market – Opportunity Analysis Index, By Product & Service, By Cancer Type, By Technology, By End User, and Region, 2020 – 2026
  2. North America Hemato-Oncology Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product & Service Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Services
      • Assay kits
    • Cancer Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Acute myeloid leukemia
      • Acute lymphocytic leukemia
      • Lymphoma
      • Non-Hodgkin lymphoma
      • Hodgkin lymphoma
      • Others
    • Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • PCR
      • IHC
      • NGS
      • Cytogenetics
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Clinical laboratories
      • Hospitals
      • Academic & Research Institutes
      • Other end user
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • USA
      • Canada
    • North America Hemato-Oncology Testing Market – Opportunity Analysis Index, By Product & Service, By Cancer Type, By Technology, By End User, and Country, 2020 – 2026
    • North America Hemato-Oncology Testing Market Dynamics – Trends
  3. Europe Hemato-Oncology Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product & Service Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Services
      • Assay kits
    • Cancer Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Acute myeloid leukemia
      • Acute lymphocytic leukemia
      • Lymphoma
      • Non-Hodgkin lymphoma
      • Hodgkin lymphoma
      • Others
    • Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • PCR
      • IHC
      • NGS
      • Cytogenetics
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Clinical laboratories
      • Hospitals
      • Academic & Research Institutes
      • Other end user
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
    • Europe Hemato-Oncology Testing Market – Opportunity Analysis Index, By Product & Service, By Cancer Type, By Technology, By End User, and Country, 2020 – 2026
    • Europe Hemato-Oncology Testing Market Dynamics – Trends
  4. Asia-Pacific Hemato-Oncology Testing Market Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    • Product & Service Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Services
      • Assay kits
    • Cancer Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Acute myeloid leukemia
      • Acute lymphocytic leukemia
      • Lymphoma
      • Non-Hodgkin lymphoma
      • Hodgkin lymphoma
      • Others
    • Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • PCR
      • IHC
      • NGS
      • Cytogenetics
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Clinical laboratories
      • Hospitals
      • Academic & Research Institutes
      • Other end user
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Hemato-Oncology Testing Market – Opportunity Analysis Index, By Product & Service, By Cancer Type, By Technology, By End User, and Country, 2020 – 2026
    • Asia-Pacific Hemato-Oncology Testing Market Dynamics – Trends
  5. Latin America Hemato-Oncology Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product & Service Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Services
      • Assay kits
    • Cancer Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Acute myeloid leukemia
      • Acute lymphocytic leukemia
      • Lymphoma
      • Non-Hodgkin lymphoma
      • Hodgkin lymphoma
      • Others
    • Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • PCR
      • IHC
      • NGS
      • Cytogenetics
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Clinical laboratories
      • Hospitals
      • Academic & Research Institutes
      • Other end user
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Latin America Hemato-Oncology Testing Market – Opportunity Analysis Index, By Product & Service, By Cancer Type, By Technology, By End User, and Country, 2020 – 2026
    • Latin America Hemato-Oncology Testing Market Dynamics – Trends
  6. Middle East and Africa Hemato-Oncology Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product & Service Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Services
      • Assay kits
    • Cancer Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Acute myeloid leukemia
      • Acute lymphocytic leukemia
      • Lymphoma
      • Non-Hodgkin lymphoma
      • Hodgkin lymphoma
      • Others
    • Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • PCR
      • IHC
      • NGS
      • Cytogenetics
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Clinical laboratories
      • Hospitals
      • Academic & Research Institutes
      • Other end user
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Hemato-Oncology Testing Market – Opportunity Analysis Index, By Product & Service, By Cancer Type, By Technology, By End User, and Country, 2020 – 2026
    • MEA Hemato-Oncology Testing Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Cancer Type & Cancer Type Product & Services, Key Developments, Strategies, and SWOT Analysis)
      • Hoffmann-La Roche Ltd.
      • Abbott Laboratories
      • Thermo Fisher Scientific Inc.
      • QIAGEN N.V.
      • Bio-Rad Laboratories
      • Illumina Inc.
      • MolecularMD
      • Invivoscribe
      • Asuragen Inc.
      • ArcherDX Inc.
  8. Research Methodology
  9. Key Assumptions and Acronyms

Report

Company Profile

Key players profile in hemato-oncology testing market include-

  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • MolecularMD
  • Invivoscribe Inc.
  • Asuragen Inc.
  • ArcherDX Inc.

Description

Hemato-Oncology Testing Market size was valued at 2.5 billion in 2021 and is expected to reach 5.8 billion by 2028, at a CAGR of 14.8% during the forecast period 2022 to 2028. There is a high rise in the number of patients suffering from blood and tumor diseases, which has been the key reason for substantial growth in the hemato-oncology market. Growing hematological cancer prevalence, developing partnerships to create new assays, and growing knowledge of customized medicines. In addition, the recent increase in the geriatric population is another integral factor driving the global demand for hemato-oncology. However, it is expected that unclear reimbursements in various regions will hinder market development. The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX